ATE339436T1 - Expression von lipoproteinen - Google Patents
Expression von lipoproteinenInfo
- Publication number
- ATE339436T1 ATE339436T1 AT96918793T AT96918793T ATE339436T1 AT E339436 T1 ATE339436 T1 AT E339436T1 AT 96918793 T AT96918793 T AT 96918793T AT 96918793 T AT96918793 T AT 96918793T AT E339436 T1 ATE339436 T1 AT E339436T1
- Authority
- AT
- Austria
- Prior art keywords
- protein
- lipidated
- disclosed
- leader sequence
- heterologous
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
- C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US48637395A | 1995-06-07 | 1995-06-07 | |
US47578195A | 1995-06-07 | 1995-06-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE339436T1 true ATE339436T1 (de) | 2006-10-15 |
Family
ID=27044930
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT96918793T ATE339436T1 (de) | 1995-06-07 | 1996-06-05 | Expression von lipoproteinen |
Country Status (13)
Country | Link |
---|---|
EP (2) | EP1741718A3 (de) |
JP (1) | JP4091112B2 (de) |
AT (1) | ATE339436T1 (de) |
AU (1) | AU721954B2 (de) |
CA (2) | CA2704354A1 (de) |
DE (1) | DE69636544T2 (de) |
DK (1) | DK0832093T3 (de) |
ES (1) | ES2271954T3 (de) |
FI (1) | FI974422A (de) |
IL (1) | IL118578A (de) |
NO (2) | NO324089B1 (de) |
PT (1) | PT832093E (de) |
WO (1) | WO1996040718A1 (de) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7008625B2 (en) | 1993-11-01 | 2006-03-07 | Research Foundation Of The State University Of New York | Recombinant constructs of Borrelia burgdorferi |
ZA964896B (en) * | 1995-06-07 | 1997-01-08 | Connaught Lab | Expression of lipoproteins |
JP4290875B2 (ja) | 1998-02-03 | 2009-07-08 | センター フォア ディズィーズ コントロール アンド プリヴェンション | 組換え脂質化PsaAタンパク質、調製法および使用 |
AU2003204215B2 (en) * | 1998-02-03 | 2007-01-11 | Aventis Pasteur | Recombinant Lipidated PsaA Protein, Methods of Preparation and Use |
EP2270030B1 (de) * | 2000-02-28 | 2012-05-23 | Novartis Vaccines and Diagnostics S.r.l. | Heterologe Expression Neisserscher Proteine |
ATE381575T1 (de) | 2000-08-18 | 2008-01-15 | Univ New York State Res Found | Veränderte borrelia burgdorferi ospa |
MY144532A (en) | 2001-08-20 | 2011-09-30 | Lundbeck & Co As H | Novel method for down-regulation of amyloid |
MX339524B (es) | 2001-10-11 | 2016-05-30 | Wyeth Corp | Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica. |
EP2314314A3 (de) | 2004-10-25 | 2011-05-11 | Statens Serum Institut | Chlamydia trachomatis antigene zur impfung und diagnostische verwendung |
EP2163255B1 (de) | 2005-06-23 | 2017-08-09 | Statens Serum Institut | Tuberkulose-Impstoffe die Antigen enthalten welche während der latenten Infektionsphase exprimiert werden |
TWI367109B (en) | 2006-01-19 | 2012-07-01 | Mary Kay Inc | Compositions comprising kakadu plum extract or acai berry extract |
US20090324638A1 (en) * | 2006-06-12 | 2009-12-31 | Biopeptides Corp. | Live bacterial vaccine |
AR064642A1 (es) | 2006-12-22 | 2009-04-15 | Wyeth Corp | Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi |
PL2199303T3 (pl) | 2008-12-12 | 2013-11-29 | Euroimmun Medizinische Labordiagnostika Ag | Polipeptydy i sposoby swoistego wykrywania przeciwciał u pacjentów z zakażeniem krętkami Borrelia |
US9074001B2 (en) | 2009-04-24 | 2015-07-07 | Statens Serum Institut | Tuberculosis TB vaccine to prevent reactivation |
CA2772626C (en) | 2009-08-28 | 2013-12-10 | Mary Kay Inc. | Skin care formulations |
KR101594228B1 (ko) | 2010-08-23 | 2016-02-15 | 와이어쓰 엘엘씨 | 네이세리아 메닌기티디스 rLP2086 항원의 안정한 제제 |
KR101584871B1 (ko) | 2010-09-10 | 2016-01-22 | 와이어쓰 엘엘씨 | 네이세리아 메닝기티디스 orf2086 항원의 비-지질화된 변이체 |
SA115360586B1 (ar) | 2012-03-09 | 2017-04-12 | فايزر انك | تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها |
MY198910A (en) | 2012-03-09 | 2023-10-02 | Pfizer | Neisseria meningitidis compositions and methods thereof |
US9802987B2 (en) | 2013-03-08 | 2017-10-31 | Pfizer Inc. | Immunogenic fusion polypeptides |
MX369534B (es) | 2013-09-08 | 2019-11-11 | Pfizer | Composiciones de neisseria meningitidis y sus metodos. |
MX2017010705A (es) | 2015-02-19 | 2017-12-04 | Pfizer | Composiciones de neisseria meningitidis y metodos de la misma. |
US10183070B2 (en) | 2017-01-31 | 2019-01-22 | Pfizer Inc. | Neisseria meningitidis compositions and methods thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4624926A (en) * | 1981-01-02 | 1986-11-25 | The Research Foundation Of State University Of New York | Novel cloning vehicles for polypeptide expression in microbial hosts |
CA2032914A1 (en) * | 1989-12-26 | 1991-06-27 | Peter C.K. Lau | Use of bacterial lipoprotein amino terminus in fusion plasmids for in vivo expression of lipid modified polypeptides |
EP0536335A4 (en) * | 1990-06-15 | 1993-07-14 | Yale University | Compositions and methods for the prevention and diagnosis of lyme disease |
CA2104014C (en) * | 1991-02-15 | 2000-05-02 | David E. Briles | Structural gene of pneumococcal protein |
ATE234365T1 (de) * | 1991-10-22 | 2003-03-15 | Symbicom Ab | Verbesserungen der diagnose und der prophylaxe von borrelia burgdorferi |
WO1994014318A1 (en) * | 1992-12-24 | 1994-07-07 | Medimmune, Inc. | Method of protection against streptococcus pneumoniae with transformed mycobacteria |
-
1996
- 1996-06-05 IL IL118578A patent/IL118578A/en not_active IP Right Cessation
- 1996-06-05 JP JP50026897A patent/JP4091112B2/ja not_active Expired - Fee Related
- 1996-06-05 DK DK96918793T patent/DK0832093T3/da active
- 1996-06-05 WO PCT/IB1996/000633 patent/WO1996040718A1/en active IP Right Grant
- 1996-06-05 CA CA2704354A patent/CA2704354A1/en not_active Abandoned
- 1996-06-05 EP EP06016140A patent/EP1741718A3/de not_active Withdrawn
- 1996-06-05 DE DE69636544T patent/DE69636544T2/de not_active Expired - Lifetime
- 1996-06-05 AU AU61343/96A patent/AU721954B2/en not_active Ceased
- 1996-06-05 AT AT96918793T patent/ATE339436T1/de active
- 1996-06-05 ES ES96918793T patent/ES2271954T3/es not_active Expired - Lifetime
- 1996-06-05 CA CA2223300A patent/CA2223300C/en not_active Expired - Fee Related
- 1996-06-05 EP EP96918793A patent/EP0832093B1/de not_active Expired - Lifetime
- 1996-06-05 PT PT96918793T patent/PT832093E/pt unknown
-
1997
- 1997-12-04 NO NO19975619A patent/NO324089B1/no not_active IP Right Cessation
- 1997-12-05 FI FI974422A patent/FI974422A/fi not_active Application Discontinuation
-
2006
- 2006-10-09 NO NO20064621A patent/NO20064621L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NO324089B1 (no) | 2007-08-13 |
AU721954B2 (en) | 2000-07-20 |
EP0832093B1 (de) | 2006-09-13 |
EP1741718A3 (de) | 2007-03-28 |
DK0832093T3 (da) | 2007-01-08 |
EP1741718A2 (de) | 2007-01-10 |
CA2223300C (en) | 2010-07-27 |
CA2223300A1 (en) | 1996-12-19 |
EP0832093A4 (de) | 2001-01-03 |
JP4091112B2 (ja) | 2008-05-28 |
JPH11514841A (ja) | 1999-12-21 |
IL118578A (en) | 2006-12-31 |
WO1996040718A1 (en) | 1996-12-19 |
NO20064621L (no) | 1998-01-30 |
IL118578A0 (en) | 1996-10-16 |
CA2704354A1 (en) | 1996-12-19 |
NO975619D0 (no) | 1997-12-04 |
EP0832093A1 (de) | 1998-04-01 |
NO975619L (no) | 1998-01-30 |
FI974422A (fi) | 1998-02-04 |
FI974422A0 (fi) | 1997-12-05 |
DE69636544D1 (de) | 2006-10-26 |
AU6134396A (en) | 1996-12-30 |
ES2271954T3 (es) | 2007-04-16 |
PT832093E (pt) | 2006-12-29 |
DE69636544T2 (de) | 2007-06-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20064621L (no) | Ekspresjon av lipoproteiner. | |
DK0397633T3 (da) | Fibronectinbindende protein samt fremstilling deraf | |
FR2704135B1 (fr) | Agrafe d'osteosynthese. | |
EP0809513A4 (de) | Verpackte rekombinante poliovirus nukleinsäure | |
DK0737207T3 (da) | Inhibitorer for humant plasmin afledt af Kunitz-domæner | |
DE68917323D1 (de) | Expressions-Vektor für Fusions-Proteine und Immunogen-Proteine. | |
EP0608120A3 (de) | Durchflusssteuerungsvorrichtung für Kapillarelektroforese. | |
NO883026L (no) | Forbedrede polyetylenmodifiserte asfalter. | |
ATE263836T1 (de) | Chimere proteine, welche borrelia polypeptide beinhalten, verwendungen dafür | |
IT1307309B1 (it) | Peptidi stabilizzanti, polipeptidi ed anticorpi che li comprendono. | |
DK295188A (da) | Fibronectinbindende protein og fremgangsmaade til fremstilling heraf | |
NL193766B (nl) | Geïsoleerde draad. | |
DE69902796D1 (de) | Verfahren zur reinigung von biomolekül- oder proteinkomplexen | |
HU9202074D0 (en) | Collagen binding protein qnd method for producing it | |
SE9602822D0 (sv) | New receptor | |
ATE301713T1 (de) | Plazentaprotein 13 | |
FR2716559B1 (fr) | Plaquette pour des opérations de marquage, de certification et/ou de contrôle. | |
DK1342729T3 (da) | Antistoffer og antisense-molekyler for G-koblet receptor der udviser selektiv affinitet for ATP | |
TR199501276A2 (tr) | Sübstitüe edilmis sikloalkilamino-ve-alkoksi-heterosaykillar, üretilmelerine mahsus usul ve zararlilarla mücadele maddesi olarak kullanilmalari. | |
NO892948D0 (no) | Modifiserte proteiner. | |
ITRM930616A0 (it) | Dispositivo perfezionato per il controllo di saldatura. | |
DE3484304D1 (de) | Streptokinase kodierende rekombinante vektoren. | |
FR2703742B1 (fr) | Soufflet en materiau elastique, destine au recouvrement de joints de transmission. | |
CA2329144A1 (en) | New peptide fragments for protein purification | |
SE9302856D0 (sv) | Method and means for producing a plasmapeotein-binding protein |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 0832093 Country of ref document: EP |